Total Payments
$1,965
2024 Payments
$374.65
Companies
15
Transactions
46
Medicare Patients
5,069
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$1,965 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,965 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $389.19 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $378.53 | 13 | $0 (2023) |
| Ardelyx, Inc. | $214.55 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $169.49 | 3 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $145.66 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $144.05 | 2 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $134.34 | 2 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $127.50 | 1 | $0 (2024) |
| Horizon Therapeutics plc | $108.40 | 4 | $0 (2021) |
| Keryx Biopharmaceuticals, Inc. | $39.43 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $374.65 | 6 | Ardelyx, Inc. ($214.55) |
| 2023 | $371.52 | 8 | Bayer Healthcare Pharmaceuticals Inc. ($145.66) |
| 2022 | $354.84 | 7 | AstraZeneca Pharmaceuticals LP ($191.97) |
| 2021 | $72.26 | 3 | AstraZeneca Pharmaceuticals LP ($43.15) |
| 2020 | $79.29 | 3 | Horizon Therapeutics plc ($79.29) |
| 2019 | $263.18 | 7 | Amgen Inc. ($183.78) |
| 2018 | $280.80 | 8 | Otsuka America Pharmaceutical, Inc. ($169.49) |
| 2017 | $168.69 | 4 | Amgen Inc. ($118.81) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/17/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $127.50 | General |
| 03/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/05/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $119.51 | General |
| Category: NEPHROLOGY | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: NEPHROLOGY | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $111.45 | General |
| Category: NEPHROLOGY | ||||||
| 09/14/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Cardio-renal | ||||||
| 02/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $120.17 | General |
| Category: Cardio-renal | ||||||
| 11/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/28/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/30/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $117.09 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/06/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/21/2022 | Amgen Inc. | AVSOLA (Biological), Enbrel | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Inflammation | ||||||
| 09/18/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/04/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: KRYSTEXXA | ||||||
| 04/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 915 | 4,640 | $2.2M | $584,122 |
| 2022 | 14 | 1,216 | 5,351 | $2.5M | $625,949 |
| 2021 | 19 | 1,459 | 6,634 | $3.2M | $758,017 |
| 2020 | 17 | 1,479 | 5,680 | $2.7M | $631,847 |
Total Patients
5,069
Total Services
22,305
Medicare Billing
$2.6M
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 199 | 2,618 | $1.2M | $266,418 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 237 | 834 | $417,500 | $123,635 | 29.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 30 | 291 | $145,500 | $87,073 | 59.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 203 | 312 | $156,000 | $46,387 | 29.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 153 | $122,400 | $27,609 | 22.6% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2023 | 44 | 225 | $123,750 | $19,600 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 69 | $27,600 | $7,586 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $15,600 | $4,702 | 30.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 51 | 66 | $2,970 | $547.14 | 18.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 18 | 22 | $1,430 | $288.64 | 20.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $880.00 | $142.56 | 16.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 13 | 13 | $845.00 | $134.55 | 15.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 210 | 2,795 | $1.3M | $246,433 | 19.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 41 | 346 | $172,500 | $107,995 | 62.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 187 | 479 | $239,700 | $76,154 | 31.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 211 | 316 | $158,000 | $54,048 | 34.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 222 | $177,600 | $41,608 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 385 | $115,500 | $30,416 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 261 | $104,325 | $27,115 | 26.0% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2022 | 51 | 301 | $165,550 | $26,975 | 16.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $18,000 | $5,553 | 30.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 87 | $30,450 | $5,406 | 17.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $8,500 | $2,171 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 35 | $7,000 | $1,641 | 23.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 22 | $1,760 | $271.22 | 15.4% |
About Dr. Ramin Gabbai, MD
Dr. Ramin Gabbai, MD is a Nephrology healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457417248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramin Gabbai, MD has received a total of $1,965 in payments from pharmaceutical and medical device companies, with $374.65 received in 2024. These payments were reported across 46 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,965).
As a Medicare-enrolled provider, Gabbai has provided services to 5,069 Medicare beneficiaries, totaling 22,305 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location West Hollywood, CA
- Active Since 12/28/2006
- Last Updated 04/09/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457417248
Products in Payments
- Parsabiv (Biological) $360.66
- LOKELMA (Drug) $270.99
- JYNARQUE (Drug) $169.49
- Kerendia (Drug) $145.66
- JESDUVROQ (Drug) $144.05
- LUPKYNIS (Drug) $134.34
- XPHOZAH 30 MG (Drug) $119.51
- KRYSTEXXA (Biological) $108.40
- FARXIGA (Drug) $107.54
- IBSRELA (Drug) $95.04
- Auryxia (Drug) $39.43
- Tymlos (Biological) $31.05
- AVSOLA (Biological) $28.53
- VORAXAZE (Drug) $26.36
- PH-Smoflipid (Drug) $19.35
- Belviq (Drug) $18.90
- KEVEYIS (Drug) $18.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in West Hollywood
Mark Barats, M.d, M.D
Nephrology — Payments: $46,849
Nephrology $46,849
Jun Shoji, M.d, M.D
Nephrology — Payments: $5,359
Nephrology $5,359
Mr. Ronald Lang, M.d, M.D
Nephrology — Payments: $1,745
Nephrology $1,745
Reiad Najjar, Md, MD
Nephrology — Payments: $729.76
Nephrology $729.76
Dr. Rana Sandhu
Nephrology — Payments: $54.52
Nephrology $54.52
Dr. Sindhu Chandran, M.b.,B.s, M.B.,B.S
Nephrology — Payments: $22.65
Nephrology $22.65